Skip to content

L - PHARMA

Active Public limited companyfounded 1994active for 31 yearsLindekensstraat 31, 2300 TurnhoutKBO/BCE: BE 0453.967.027

Annual accounts 2025

micro format, filed on 31-07-2026, on the day of the deadline
-€3,714
▼ €2,421
-€3,834
▼ €2,260
-€3,853
▼ €2,239
-€9,185
▼ €3,853
-
-

The micro format does not require turnover, and these accounts state none. Without turnover there is no EBIT margin either.

Balance sheet

balance sheet total €10 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
--1,5029988510,28313,3077,1212,4268,72611,123-2,824-11,255-5,413-6,137-11,363-36,78114,411-33,841-43,318-15,860
--1,5405284010,24213,2671,2172,2438,52111,092-240,516-11,302-5,454-6,197-11,452-37,09917,472-37,887-43,852-15,975
-00036002790639020,9903013,710372487516016,6009,6501
-86-70149-1,0239117039-837815-1,4281,433-549-13,101---2,123---
-9,185-5,332-3,792-3,844316-4,565-17,832-24,487-26,730-34,612-555,705-531,593-519,990-510,826-504,257-509,132-469,305-484,692-435,961-389,294
------------115.6%-110.9%-109.3%-98.6%-88.8%-67.6%-77.3%-63.9%-38.3%
-------0.000.320.200.010.000.000.000.030.010.060.010.010.16
--------22.0%12.3%22.0%-789.4%-5.0%-2.6%-4.0%-5.7%-14.8%4.7%-14.8%-16.9%-4.8%
--38.902.1319.50over 100---------------

The ratios are withheld because a balance sheet total of €10 is too small for a meaningful ratio.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
Balance sheet: assets
20/58 10964896101,3534,0843,18110,14827,30327,60731,118247,375246,758244,462261,035272,914298,633279,491273,091335,855
21/28 --731933139318610,12814,59919,13124,164245,698246,432243,697246,920267,341270,248273,568268,242260,756
21 ---------7001,4002,1002,800-------
22/27 --73193313931864,4118,88212,71417,0474875217964,0197,0539,96013,2807,954468
24 --73193313931864,4118,88212,71417,0474875217964,0197,0539,96013,2807,954468
28 -------5,7175,7175,7175,717243,111243,111242,901242,901260,288260,288260,288260,288260,288
29/58 10964164171,0403,9912,9952012,7048,4766,9551,67832676514,1155,57328,3855,9234,84975,099
40/41 --250400-3,8252,900-12,6008,4506,8618051391985,38628,1413,4764,84975,099
40 ---400-3,8252,900-12,6008,4506,861----5,37827,9322,32338926,077
41 --250--------80513919882101,1534,46049,022
54/58 1096166171,040129592010426111,438555513,656-242,147--
490/1 -----3736---8316031672261187219300--
Balance sheet: equity and liabilities
10/49 10964896101,3534,0843,18110,14827,30327,60731,118247,375246,758244,462261,035272,914298,633279,491273,091335,855
10/15 -509,185-505,332-503,719-503,651-504,371-514,472-527,646-524,359-522,131-525,481-531,541-285,895-273,558-267,130-257,337-242,365-201,844-215,995-174,554-128,538
10/11 74,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,368
10 74,36874,36874,36874,36874,368---------------
100 74,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,36874,368
13 ----26,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,029---
133 ----26,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,02926,029---
14 -583,553-579,700-578,087-578,019-604,768-614,869-628,043-624,756-622,528-625,878-631,938-386,292-373,955-367,526-357,734-342,762-302,240-290,363-248,922-202,906
17/49 509,194505,428504,208504,261505,724518,556530,827534,508549,434553,088562,659533,271520,316511,592518,373515,279500,477495,487447,645464,393
17 500,000500,000500,000500,000505,000510,000510,000510,000510,000510,000-----5742,7874,8716,835-
170/4 500,000500,000500,000500,000505,000510,000510,000510,000510,000510,000-----5742,7874,8716,835-
42/48 9,1945,4284,2084,2617248,55620,82724,50839,43443,088562,659533,271520,316511,592518,373514,705497,689490,615440,810464,393
42 --------------5742,2132,9022,7812,667818
43 ---------------10069,35272,07972,40873,064
430/8 ---------------10069,35272,07972,40873,064
44 2,0131,3631,093826--1794034391751,1011,204273-413611,2512833,6232,028
440/4 2,0131,3631,093826--1794034391751,1011,204273-413611,2512833,6232,028
45 ------145145165---6855813856----
450/3 ------145145165---6855813856----
47/48 7,1824,0653,1153,4357248,55620,50423,95938,83142,913561,558532,067519,357511,011517,373512,024424,185415,472362,112388,483
Income statement
9900 -3,714-1,2942981,07710,47413,4077,2192,5228,82011,528-2,614-9,867-5,012-5,684-10,736-36,358-11,032-33,337-16,009-15,349
62 ------------------347-
630 -73120120140934,5044,4715,1715,0335,1301,0359753,5953,5213,4233,3203,5542,164234
631/4 -----------------26,029-26,029-
640/8 1202081991921911009896944042101,388401453626423586504933511
66A ----------237,184------3,505--
9901 -3,834-1,575-2176510,14313,2142,617-2,0453,5556,091-7,954-12,291-6,388-9,732-14,883-40,20411,091-37,394-45,482-16,094
75/76B 9-----237,184--10-0-2--3,4781--
75 9--------10-0-2--3,4781--
76B ------237,184-------------
65/66B 273946454143242,94539404150847416389317417542534115
65 2739464541434439404150847416389317417542534115
66B ------242,901-------------
9903 -3,853-1,613-6872010,10213,172-3,144-2,0843,5156,060-245,646-12,337-6,428-9,792-14,972-40,52214,152-41,441-46,016-16,209
67/77 ------2143143165-----------
9904 -3,853-1,613-6872010,10213,174-3,287-2,2283,3506,060-245,646-12,337-6,428-9,792-14,972-40,52214,152-41,441-46,016-16,209
9905 -3,853-1,613-6872010,10213,174-3,287-2,2283,3506,060-245,646-12,337-6,428-9,792-14,972-40,52214,152-41,441-46,016-16,209
Appropriation of the result
9906 -583,553-579,700-578,087-604,048-604,768-614,869-628,043-624,756-622,528-625,878-631,938-386,292-373,955-367,526-357,734-342,762-276,212-290,363-248,922-202,906
14P -579,700-578,087-578,019-604,768-614,869---------------
791/2 ---26,029----------------
691/2 ----------------26,029---
6921 ----------------26,029---
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 10 older financial years, from 1995 to 2005, were filed as documents without figures as data, scans for example.

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 31-07-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 31-07-2026 2026-00361763 PDF
31-12-2024 micro format 31-07-2025 2025-00339408 PDF
31-12-2023 micro format 29-06-2024 2024-00182516 PDF
31-12-2022 micro format 31-08-2023 2023-00390359 PDF
31-12-2021 micro format 17-06-2022 2022-20069055 PDF
31-12-2020 micro format 31-08-2021 2021-58700271 PDF
31-12-2019 micro format 31-07-2020 2020-36700485 PDF
31-12-2018 micro format 31-07-2019 2019-41600132 PDF
31-12-2017 micro format 30-07-2018 2018-39900338 PDF
31-12-2016 micro format 31-07-2017 2017-38600157 PDF
31-12-2015 abbreviated format 29-07-2016 2016-37700410 PDF
31-12-2014 abbreviated format 30-08-2015 2015-53600382 PDF
31-12-2013 abbreviated format 29-07-2014 2014-39100235 PDF
31-12-2012 abbreviated format 30-08-2013 2013-56900517 PDF
31-12-2011 abbreviated format 13-06-2012 2012-17300009 PDF
31-12-2010 abbreviated format 26-05-2011 2011-12300568 PDF
31-12-2009 abbreviated format 15-07-2010 2010-30800012 PDF
31-12-2008 abbreviated format 26-06-2009 2009-31500035 PDF
31-12-2007 abbreviated format 02-07-2008 2008-34400267 PDF
31-12-2006 abbreviated format 30-08-2007 2007-67500025 PDF
31-12-2005 abbreviated format 13-07-2006 2006-46203875 PDF
31-12-2004 abbreviated format 26-08-2005 2005-65300077 PDF
31-12-2003 abbreviated format 30-07-2004 2004-53400155 PDF
31-12-2002 abbreviated format 30-07-2003 2003-50500221 PDF
31-12-2000 abbreviated format 26-10-2001 2001-65800254 PDF
31-12-1999 abbreviated format 27-10-2000 2000-68100001 PDF
31-12-1998 abbreviated format 25-10-1999 1999-54702159 PDF
31-12-1997 abbreviated format 11-06-1998 1998-16200904 PDF
31-12-1996 abbreviated format 06-06-1997 1997-12800396 PDF
31-12-1995 abbreviated format 23-05-1996 1996-09703112 PDF

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets----€360
-€73€120€120€140

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on L - PHARMA

The operating result for 2025 is a loss of €3,834, larger than the loss of €1,575 in 2024. It is the lowest result since 2015.

Equity is negative. Debt of €509,194 exceeds the balance-sheet total of €10.

Next steps